Trials in Chicago, Illinois
Here are the top 10 medical studies for alzheimer's disease in Chicago, Illinois
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Investigational Alzheimer's Drugs for Early Onset Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Park Ridge, Illinois
This trial tests two drugs, lecanemab and E2814, in people with a genetic mutation that causes Alzheimer's disease. Lecanemab helps remove harmful protein clumps from the brain, while E2814 prevents harmful protein tangles from forming. The goal is to see if these drugs can slow down or improve symptoms of Alzheimer's.
Monoclonal Antibodies
Donanemab for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Fayetteville, Arkansas
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.
Behavioural Intervention
KarXT for Alzheimer's-Related Psychosis
Recruiting1 awardPhase 3
Elgin, Illinois
This trial is testing KarXT, a medication for adults aged 55-90 with Alzheimer's Disease and severe psychosis. The goal is to see if KarXT can reduce symptoms like hallucinations and delusions by balancing brain chemicals.
Trials With No Placebo
Behavioral Intervention
OTC Hearing Aid for Cognitive Impairment
Recruiting1 award3 criteria
Evanston, Illinois
This trial aims to see if Over-the-Counter (OTC) hearing aids can help improve communication in patients with mild to moderate hearing loss and mild cognitive impairment or Alzheimer's disease. The study will
Behavioral Intervention
Improvised Music for Alzheimer's Disease
Recruiting1 award
Chicago, Illinois
This trial aims to study the effects of a type of calming improvised music called Clinically Designed Improvisatory Music (CDIM) on reducing anxiety in both healthy individuals and Alzheimer's patients with anxiety.
Behavioral Intervention
Coaching for Dementia Care
Recruiting1 award
Chicago, Illinois
"This trial aims to see if staff in long-term care communities benefit from a specific intervention. They want to know if the intervention affects employee satisfaction and confidence in dementia care. The intervention group will receive coaching
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.